Product image of Metformina Pharmconsul (Metformin Hydrochloride) supplied by GNH India

Metformina Pharmconsul

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformina Pharmconsul (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metformina Pharmconsul, is a biguanide presented as an oral tablet for oral use. It is employed to improve glycemic control in adults with type 2 diabetes mellitus, and it works by decreasing hepatic glucose output and enhancing peripheral insulin sensitivity as part of a comprehensive lifestyle modification program.

GNH India supplies Metformina Pharmconsul as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Pharmconsul S.R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metformina Pharmconsul, a biguanide antidiabetic agent, is used to manage disorders of glucose metabolism.

  • Type 2 diabetes mellitus: improves blood glucose control and reduces HbA1c levels.
  • Prediabetes (impaired glucose tolerance): delays progression to overt diabetes when combined with diet and exercise.
  • Gestational diabetes mellitus: may be used as an adjunct when insulin therapy is not suitable.

How It Works

  • Metformin Hydrochloride acts primarily by inhibiting hepatic gluconeogenesis, thereby reducing endogenous glucose production. It also increases peripheral glucose uptake by enhancing insulin‑mediated activation of AMP‑activated protein kinase (AMPK), which improves insulin sensitivity in muscle and adipose tissue, leading to lower circulating blood glucose levels.

Side Effects

Metformina Pharmconsul may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools, often early in therapy.
  • Abdominal discomfort: cramping or bloating.
  • Metallic taste: transient alteration of taste perception.
  • Loss of appetite: reduced desire to eat.
  • Flatulence: increased intestinal gas.

Serious or Rare Side Effects

  • Lactic acidosis: rare but life‑threatening metabolic acidosis.
  • Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Hepatic dysfunction: elevated liver enzymes or hepatitis.
  • Hypoglycemia: when combined with insulin or sulfonylureas.
  • Vitamin B12 deficiency: long‑term use may reduce B12 absorption.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor relevant parameters.

  • Renal function: assess creatinine clearance and avoid use in severe renal impairment.
  • Hepatic function: evaluate liver enzymes, especially in patients with existing liver disease.
  • Risk of lactic acidosis: avoid in conditions predisposing to hypoxia or tissue hypoperfusion.
  • Concomitant medications: review drugs that may affect renal clearance or increase acidosis risk.
  • Elderly patients: start at lower doses and monitor tolerance closely.
  • Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Avoid Interactions

Metformina Pharmconsul can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk.
  • Alcohol excess: enhances risk of lactic acidosis.
  • Cimetidine: can increase metformin plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask hypoglycemia symptoms.
  • ACE inhibitors or ARBs: can affect renal function, requiring dose adjustment.
  • Diuretics: may reduce renal clearance of metformin.
  • Calcium channel blockers: occasional increase in metformin levels.
  • Sulfonylureas: heightened risk of hypoglycemia when combined.

Frequently Asked Questions

Metformina Pharmconsul contains metformin hydrochloride and is prescribed to improve blood glucose control in adults with type 2 diabetes mellitus. It may also be considered for prediabetes or gestational diabetes when appropriate, always as part of a broader management plan that includes diet and exercise.

Metformin hydrochloride reduces hepatic glucose production and enhances peripheral insulin sensitivity. It activates AMP‑activated protein kinase (AMPK), which suppresses gluconeogenesis in the liver and promotes glucose uptake in muscle and fat tissue, thereby lowering circulating blood sugar levels.

The exact dose of Metformina Pharmconsul is determined by the prescribing healthcare professional based on the individual’s renal function, glycemic targets, and overall treatment plan. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

The safety of metformin during pregnancy or lactation is not fully established. It may be used in certain cases of gestational diabetes under close medical supervision, but the prescriber will weigh potential benefits against risks. Breastfeeding mothers should discuss continuation with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metformina Pharmconsul belongs to the biguanide class, which differs from sulfonylureas, DPP‑4 inhibitors, or insulin. Unlike insulin, it does not cause hypoglycemia when used alone, and unlike sulfonylureas, it does not stimulate insulin secretion. Its primary advantage is improving insulin sensitivity and reducing hepatic glucose output.

Metformina Pharmconsul should be stored at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the tablet bottle tightly closed and out of reach of children.

Metformina Pharmconsul is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets are swallowed whole with a glass of water. The exact timing and frequency are set by the prescriber based on the patient’s therapeutic goals.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or conditions causing hypoxia. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformina Pharmconsul is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or those receiving iodinated contrast studies without adequate hydration. Clinicians should assess each patient’s medical history before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT